BioCorRx BICX
OTC BICX
$0.25 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

BioCorRx (BICX) Convertible Debt (2012 - 2019)

Updated

BioCorRx (BICX) recorded Convertible Debt of $4.16 million in Q4 2019, unchanged from the prior quarter.

Analysis

BioCorRx (BICX) Convertible Debt (2012 - 2019) Analysis & Trends

Starting with Q4 2012, BioCorRx's Convertible Debt history includes 17 quarters.

  • Annual Convertible Debt has a four-year compound annual growth rate of 423.7% (FY2015 to FY2019).
  • Across earlier years, Convertible Debt came in at $2.02 million in FY2017 (+192.7%), $688,783 in FY2016 and $5,530 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 BioCorRx 4.32 Mn 3.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 4.16 Mn
Sep 30, 2019 4.16 Mn
Mar 31, 2018 2.38 Mn
Dec 31, 2017 2.02 Mn
Sep 30, 2017 1.64 Mn
Jun 30, 2017 1.27 Mn
Mar 31, 2017 895,149.00
Dec 31, 2016 688,783.00
Sep 30, 2016 501,766.00
Jun 30, 2016 314,749.00
Dec 31, 2015 5,530.00
Sep 30, 2015 685.00
Jun 30, 2015 13,280.00
Mar 31, 2015 4,063.00
Dec 31, 2013 601,328.00
Mar 31, 2013 23,116.00
Dec 31, 2012 5,708.00
API Access

BioCorRx Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=BICX&period=max&api_key=YOUR_API_KEY